PETER FECCI, MD, PHDDuke University
The CARE-BEAR Proposal
Glioblastoma
This grant was made in memory of our dear friend, Kristen Grossman.
DARYA ALIZADEH, PHDCity of Hope
Advancing IL13Ra2-CAR T cell Therapy against Glioblastoma by Enhancing IFN-Signaling
CLAIRE VANPOUILLE-BOX, PHDWeill Cornell Medicine
Regulation of myeloid cells by fatty acid metabolism in irradiated Glioblastoma
SACHET SHUKLA, PHDMD Anderson Cancer Center
Identification of non-canonical antigens of development of novel immunotherapies in Glioblastoma
STAVROULA SOFOU, PHDJohns Hopkins University
Alpha- particle radiotherapy for glioblastoma
Glioblastoma - Treatment
QIANG LU, PHDBeckman Research Institute of City of Hope
Engineering inhibitors of the ERKS axis proteins for glioblastoma treatment
APARNA BHADURI, PHDThe Regents of the University of California, Los Angeles
Characterizing PTPRZ1 Mechanism in Cancer as a Therapeutic Target
LIN HUI, PHDUniversity of California, San Francisco
Developing Multimodal Deep Learning for Outcome Prediction in Glioblastoma Patients after Radiation Therapy
JANINE LUPO, PHDUniversity of California, San Francisco
Targeting CAFs to sensitize irradiated glioblastoma to PD-1 blockade
NATHAN DAHL, MDUniversity of Colorado
PTEFb-dependent transcriptional reorganization in the glioma adaptive response to radiotherapy
Pediatric - High Grade Gliomas - Treatment
HUGO GUERRERO-CAZARES, MD, PHD Mayo Clinic
Targeting the malignant interaction between glioblastoma and the subventricular zone
Glioblastoma - Science
BETTY KIM, MD, PHDMD Anderson Cancer Center
Microbial-Inspired STING Activation for Glioblastoma Immunotherapy
Glioblastoma - Immunotherapeutic treatments
MATTHEW WAITKUS, PHDDuke University
Synthetic lethal strategies for targeting ATRX deficiency and the Alternative Lengthening of Telomeres in Pediatric High-Grade Gliomas
Pediatric - Gliomas
MARGARITA GUTOVA, MDCity of Hope
Overcoming Resistance to CAR T Immunotherapy with CBP/β-catenin Antagonists ICG-001 in BrainTumors: The Road Ahead Towards Metabolic Enhancement of Cancer Immunotherapy
Gliomas and Ependymomas - Treatment
JIAN HU, PHD MD Anderson Cancer Center
Epigenetic Regulation in Pediatric High-Grade Gliomas
LIOR MAYO, PHDTel Aviv University
Targeting Astrocyte Metabolic Reprogramming in Glioblastoma
ALBERT LAI, MD, PHDUniversity of Los Angeles, California
Paracrine effect of glioma metabolism on immune epigenetics
Glioma - Science
VIDYA GOPALAKRISHNAN, PHD MD Anderson Cancer Center
Repurposing Migraine Treatments for DIPG
Pediatric - DIPG Treatment
FLORIAN MULLER, PHDMD Anderson Cancer Center
Angiogenesis Inhibited Tumors are Vulnerable to Inhibitor of Oxidative Phosphorylation
SANTOSH KESARI, MD, PHDJohn Wayne Cancer Institute
Optimization of OLIG2 inhibition for Glioblastoma treatment
MANISH AGHI, MD, PHDUniversity of California, San Francisco
Defining and targeting pro-tumoral effects of cancer-associated fibroblasts in glioblastoma
Targeting metabolic reprogramming in pediatric medulloblastoma
Pediatric - Medulloblastoma
FREDERICK F. LANG, MD, FACS, FAANS, FAAASMD Anderson Cancer Center
Super-selective Intra-arterial Infusion of Human Mesenchymal Stem Cell-based Therapy in a Rabbit Human Glioblastoma Model
ELMAR NURMEMMEDOV, PHDJohn Wayne Cancer Institute
Targeting inhibition of Beta-catenin in medulloblastoma
Medulloblastoma
DAVID A. NATHANSON, PHDUniversity of California, Los Angeles
Comprehensive characterization of apoptotic blocks in Glioblastoma
ROBERT M. PRINS, PHDUniversity of California, Los Angeles
Identification and cloning of neoantigen-specific T Cells for Glioblastoma immunotherapy
CHRISTOPHER J. WHEELER, PHDCedars-Sinai Medical Center
Combination Immunotherapy and Precision Medicine to treat Glioblastoma
JUNBAO YANG, MD, PHDJohn Wayne Cancer Institute
Searching the targets on Glioblastoma for immune cells to attack. Specifically, antigen-specific T Cells and antigenic epitope discovery for immunotheraphy